Company Filing History:
2 out of 2,168 
1 out of 81 
Years Active: 2022-2025
Title: Jaeyoung Kwon: Innovator in Neurodegenerative Disorder Treatments
Introduction
Jaeyoung Kwon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurodegenerative disorders. With a total of 2 patents, Kwon's work is recognized for its innovative approach to addressing critical health issues.
Latest Patents
Kwon's latest patents include a novel triterpene saponin derivative, specifically astersaponin I, which has been isolated and identified from a Korean starwort extract. This patent focuses on the use of this compound for preventing or treating neurodegenerative disorders. Another significant patent involves a pharmaceutical composition that includes an extract aimed at preventing or treating ischemia-reperfusion injury. This composition is designed to be used in both food and pharmaceutical applications.
Career Highlights
Throughout his career, Jaeyoung Kwon has worked with esteemed institutions such as the Korea Institute of Science and Technology and the University of Ulsan Foundation for Industry Cooperation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kwon has collaborated with notable colleagues, including Hak Cheol Kwon and Hyun Ok Yang. These partnerships have further enriched his research and development efforts in the field of pharmaceuticals.
Conclusion
Jaeyoung Kwon's innovative work in developing treatments for neurodegenerative disorders and ischemia-reperfusion injury highlights his significant contributions to the field of medicine. His patents reflect a commitment to advancing healthcare solutions that can improve patient outcomes.